Thus, this data demonstrates that circulating syndecan-1 is reduced in women with underlying vascular disease preceding the diagnosis of placental insufficiency (SGA/PE) relative to uncomplicated pregnancies. This evidence concerns the gene SDC1 and placental insufficiency.